Beitollahi, Mina
Forouzi, Mansooreh Azizzadeh
Tirgari, Batool
Jahani, Yunes
Article History
Received: 8 November 2021
Accepted: 15 April 2022
First Online: 22 April 2022
Declarations
:
: This study was approved by the Ethics Committee of Kerman University of Medical Science with the code of ethics No. (IR.KMU.REC. 1398.263). The clinical trial code (IRCT20151107024919N11) was received from the Iranian Clinical Trial Registration Center on 22/10/ 2020. At the request of the Ethical committee, the study was conducted in accordance with the Declaration of Helsinki and Ethics Publication on Committee (COPE). Written informed consent was obtained from the patients. There was no ethical issue during the study and data collection. Furthermore, the participants were informed that they could withdraw from the study at any time. Moreover, they were ensured about confidentiality of information. Informed consent was obtained from all nurses. For the participations’ information confidentiality to be ensured special codes were allocated to each questionnaire and the data were analyzed using these codes.
: Not applicable.
: The authors declare that they have no competing interests.